[Hepatic arterial embolisation. 35 cases (author's transl)].
Thirty five cases of hepatic arterial embolisation are reported. The analgesic effect in association with tumour pathology (27 cases) was virtually constant (80% of cases). Arterial embolisation should thus replace surgical disarterialisation in the management of malignant tumours of the liver. It improves the quality of survival in painful tumours, above all when they are hypervascularised. Two fatal complications as a result of the technique emphasise the absolute need to respect its contraindications: portal thrombosis, even segmental, or hepatic failure. Two cavernous haemangiomas and one angioma with arterioportal fistula complicated by haemobilia were also successfully embolised. Five traumatic vascular lesions, two of which resulted in severe haemobilia, also benefited from superselective embolisation.
D001164:Arteriovenous Fistula / Q000628:therapy; D004621:Embolization, Therapeutic / Q000009:adverse effects; D005260:Female; D006391:Hemangioma / Q000628:therapy; D006470:Hemorrhage / Q000628:therapy; D006499:Hepatic Artery; D006801:Humans; D008099:Liver / Q000293:injuries; D008113:Liver Neoplasms / Q000628:therapy; D008297:Male; D059408:Pain Management
L'embolisation artérielle hépatique. 35 cas.